Ptc Therapeutics reported $10.14M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
TG Therapeutics TGTX:US 237K 27K
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Alnylam Pharmaceuticals ALNY:US $ 35.63M 2.04M
Amgen AMGN:US $ 1561M 157M
Biocryst Pharmaceuticals BCRX:US $ 0.24M 0.18M
Biogen BIIB:US $ 753.9M 93.8M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Daiichi Sankyo 4568:JP Y 88830M 3109M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
Gilead Sciences GILD:US $ 1424M 1203M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
IONIS PHARMACEUT IONS:US $ 4.17M 1.94M
Karyopharm Therapeutics KPTI:US $ 1.43M 684K
Novartis NOVN:VX SF 3755M 245M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Puma Biotechnology PBYI:US $ 10.84M 1.05M
Sarepta Therapeutics SRPT:US $ 31.44M 0.3M
Ultragenyx Pharmaceutical RARE:US $ 6.1M 2.59M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M
YTE INCY:US $ 37.21M 1.36M